72 related articles for article (PubMed ID: 8833330)
21. ErbB2 and EGFR are downmodulated during the differentiation of 3T3-L1 preadipocytes.
Pagano E; Calvo JC
J Cell Biochem; 2003 Oct; 90(3):561-72. PubMed ID: 14523990
[TBL] [Abstract][Full Text] [Related]
22. Recombinant heregulin-Pseudomonas exotoxin fusion proteins: interactions with the heregulin receptors and antitumor activity in vivo.
Yang D; Kuan CT; Payne J; Kihara A; Murray A; Wang LM; Alimandi M; Pierce JH; Pastan I; Lippman ME
Clin Cancer Res; 1998 Apr; 4(4):993-1004. PubMed ID: 9563895
[TBL] [Abstract][Full Text] [Related]
23. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
St-Laurent V; Sanchez M; Charbonneau C; Tremblay A
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):23-37. PubMed ID: 15862947
[TBL] [Abstract][Full Text] [Related]
24. Peptide aptamers with binding specificity for the intracellular domain of the ErbB2 receptor interfere with AKT signaling and sensitize breast cancer cells to Taxol.
Kunz C; Borghouts C; Buerger C; Groner B
Mol Cancer Res; 2006 Dec; 4(12):983-98. PubMed ID: 17189388
[TBL] [Abstract][Full Text] [Related]
25. Changes in heregulin beta1 (HRGbeta1) signaling after inhibition of ErbB-2 expression in a human breast cancer cell line.
Yoo JY; Hamburger AW
Mol Cell Endocrinol; 1998 Mar; 138(1-2):163-71. PubMed ID: 9685225
[TBL] [Abstract][Full Text] [Related]
26. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis.
Weinstein EJ; Leder P
Cancer Res; 2000 Jul; 60(14):3856-61. PubMed ID: 10919660
[TBL] [Abstract][Full Text] [Related]
27. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
Frohnert PW; Stonecypher MS; Carroll SL
Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic activity of chimeric toxins containing the epidermal growth factor-like domain of heregulins fused to PE38KDEL, a truncated recombinant form of Pseudomonas exotoxin.
Kihara A; Pastan I
Cancer Res; 1995 Jan; 55(1):71-7. PubMed ID: 7805044
[TBL] [Abstract][Full Text] [Related]
29. Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity.
Altiok N; Altiok S; Changeux JP
EMBO J; 1997 Feb; 16(4):717-25. PubMed ID: 9049301
[TBL] [Abstract][Full Text] [Related]
30. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
[TBL] [Abstract][Full Text] [Related]
31. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin.
Sliwkowski MX; Schaefer G; Akita RW; Lofgren JA; Fitzpatrick VD; Nuijens A; Fendly BM; Cerione RA; Vandlen RL; Carraway KL
J Biol Chem; 1994 May; 269(20):14661-5. PubMed ID: 7514177
[TBL] [Abstract][Full Text] [Related]
32. Heregulin activation of ErbB2/ErbB3 signaling potentiates the integrity of airway epithelial barrier.
Gon Y; Matsumoto K; Terakado M; Sekiyama A; Maruoka S; Takeshita I; Kozu Y; Okayama Y; Ra C; Hashimoto S
Exp Cell Res; 2011 Aug; 317(13):1947-53. PubMed ID: 21624363
[TBL] [Abstract][Full Text] [Related]
33. ErbB3 and ErbB2/neu mediate the effect of heregulin on acetylcholine receptor gene expression in muscle: differential expression at the endplate.
Altiok N; Bessereau JL; Changeux JP
EMBO J; 1995 Sep; 14(17):4258-66. PubMed ID: 7556067
[TBL] [Abstract][Full Text] [Related]
34. Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays.
Sadick MD; Intintoli A; Quarmby V; McCoy A; Canova-Davis E; Ling V
J Pharm Biomed Anal; 1999 May; 19(6):883-91. PubMed ID: 10698554
[TBL] [Abstract][Full Text] [Related]
35. Formation of a high affinity heregulin binding site using the soluble extracellular domains of ErbB2 with ErbB3 or ErbB4.
Fitzpatrick VD; Pisacane PI; Vandlen RL; Sliwkowski MX
FEBS Lett; 1998 Jul; 431(1):102-6. PubMed ID: 9684874
[TBL] [Abstract][Full Text] [Related]
36. Cross-talk between phorbol ester-mediated signaling and tyrosine kinase proto-oncogenes. II. Comparison of phorbol ester and sphingomyelinase-induced phosphorylation of ErbB2 and ErbB3.
Emkey R; Kahn CR
J Biol Chem; 1997 Dec; 272(49):31182-9. PubMed ID: 9388272
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the characteristic of estrogenic action patterns of beta-HCH and heregulin beta1 in MCF-7 human breast cancer cells.
Hatakeyama M; Zou E; Matsumura F
J Biochem Mol Toxicol; 2002; 16(5):209-19. PubMed ID: 12439862
[TBL] [Abstract][Full Text] [Related]
38. Insulin regulates heregulin binding and ErbB3 expression in rat hepatocytes.
Carver RS; Sliwkowski MX; Sitaric S; Russell WE
J Biol Chem; 1996 Jun; 271(23):13491-6. PubMed ID: 8662847
[TBL] [Abstract][Full Text] [Related]
39. ErbB receptor expression and growth response to heregulin beta 1 in five ovarian carcinoma lines.
Pegues JC; Kannan B; Stromberg K
Int J Oncol; 1999 Jun; 14(6):1169-76. PubMed ID: 10339675
[TBL] [Abstract][Full Text] [Related]
40. The erbB3 gene product is a receptor for heregulin.
Carraway KL; Sliwkowski MX; Akita R; Platko JV; Guy PM; Nuijens A; Diamonti AJ; Vandlen RL; Cantley LC; Cerione RA
J Biol Chem; 1994 May; 269(19):14303-6. PubMed ID: 8188716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
